Celldex Therapeutics Inc (CLDX)

Celldex (CLDX) Stock Price & Analysis


CLDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$25.19 - $48.40
Previous Close$25.45
Average Volume (3M)424.36K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$252.70M
Total Debt (Recent Filing)$3.25M
Price to Earnings (P/E)-10.6
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.40
Shares Outstanding47,260,804
10 Day Avg. Volume423,722
30 Day Avg. Volume424,361
Standard Deviation0.57
Financial Highlights & Ratios
Price to Book (P/B)4.96
Price to Sales (P/S)4627.33
Price to Cash Flow (P/CF)-11.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside120.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Celldex Therapeutics Inc’s price range in the past 12 months?
Celldex Therapeutics Inc lowest stock price was $25.19 and its highest was $48.40 in the past 12 months.
    What is Celldex Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Celldex Therapeutics Inc’s upcoming earnings report date?
    Celldex Therapeutics Inc’s upcoming earnings report date is Nov 08, 2023 which is in 45 days.
      How were Celldex Therapeutics Inc’s earnings last quarter?
      Celldex Therapeutics Inc released its earnings results on Aug 08, 2023. The company reported -$0.65 earnings per share for the quarter, beating the consensus estimate of -$0.658 by $0.008.
        Is Celldex Therapeutics Inc overvalued?
        According to Wall Street analysts Celldex Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Celldex Therapeutics Inc pay dividends?
          Celldex Therapeutics Inc does not currently pay dividends.
          What is Celldex Therapeutics Inc’s EPS estimate?
          Celldex Therapeutics Inc’s EPS estimate is -$0.68.
            How many shares outstanding does Celldex Therapeutics Inc have?
            Celldex Therapeutics Inc has 47,260,803 shares outstanding.
              What happened to Celldex Therapeutics Inc’s price movement after its last earnings report?
              Celldex Therapeutics Inc reported an EPS of -$0.65 in its last earnings report, beating expectations of -$0.658. Following the earnings report the stock price went down -5.832%.
                Which hedge fund is a major shareholder of Celldex Therapeutics Inc?
                Among the largest hedge funds holding Celldex Therapeutics Inc’s share is Woodline Partners LP. It holds Celldex Therapeutics Inc’s shares valued at 2M.


                  Celldex Stock Smart Score

                  The Celldex stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Celldex Therapeutics Inc

                  Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.


                  Top 5 ETFs holding CLDX

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Fidelity Nasdaq Composite Index ETF
                  Schwab U.S. Broad Market ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold CLDX. The ETFs are listed according to market value of CLDX within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Abeona Therapeutics
                  Corcept Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis